Showing 65–80 of 515 results
An ANA (antinuclear antibody) test using immunofluorescence measures the presence and amount of antinuclear antibodies in the blood, which can indicate an overactive immune system and potentially autoimmune diseases. The test results are reported as a titer (a measure of the antibody level) and a staining pattern.
The ANA test is a blood test that detects antinuclear antibodies (ANAs) in the blood.
ANAs are antibodies that mistakenly target the nucleus of the body’s own cells, potentially leading to inflammation and autoimmune conditions.
The test typically uses an indirect immunofluorescence assay (IFA), where a sample of your blood is mixed with a fluorescent dye-labeled antibody that binds to the ANAs, if present.
The test measures the level of ANAs in your blood, which is reported as a titer.
A positive ANA test can suggest an autoimmune disorder, but it’s not a definitive diagnosis and further testing is often needed.
The titer is a measure of the amount of ANAs in your blood, expressed as a ratio (e.g., 1:40, 1:80, 1:160).
A higher titer indicates a greater amount of ANAs, which may be more indicative of an autoimmune condition.
While some healthy individuals may have low levels of ANAs, a high titer is more likely to suggest an autoimmune disorder.
Some labs may consider a titer above a certain level (e.g., 1:160) as positive, but this can vary.
Some common patterns include homogeneous, speckled, centromere, and others.
Your doctor may order an ANA test if you have symptoms of an autoimmune disease, such as fatigue, joint pain, skin rashes, or other symptoms.
ANA tests are often used to help diagnose autoimmune diseases like Systemic Lupus Erythematosus (SLE or lupus), Rheumatoid Arthritis, and other connective tissue disorders.
An antenatal profile, also known as an ANC profile, is a series of blood and urine tests that assess the health of a pregnant woman and her fetus. It’s a key part of antenatal care and is usually recommended during the first trimester.